Do Us Payers Consider Cost-Effectiveness when Defining...

Value in Health 2018 / 05 Vol. 21

Do Us Payers Consider Cost-Effectiveness when Defining Prescription Benefits? A Study of Targeted Therapies for Rheumatoid Arthritis and Moderate-To-Severe Psoriasis

Borga, P, Pinedo-Martin, G, Ribeiro, A
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.04.1723
Date:
May, 2018
File:
PDF, 82 KB
english, 2018
Conversion to is in progress
Conversion to is failed